Huyen Q. Pham

Huyen Q. Pham

Assistant Professor of Clinical Obstetrics & Gynecology;Director of the Gynecology/Oncology Clinic
Obstetrics & Gynecology
IRD 520 2020 Zonal Ave Off Campus Los Angeles

Immune Activation in Patients with Locally Advanced Cervical Cancer Treated with Ipilimumab Following Definitive Chemoradiation (GOG-9929) Clin Cancer Res. 2020 Nov 01; 26(21):5621-5630. . View in PubMed

Implementation of multidisciplinary practice change to improve outcomes for women with placenta accreta spectrum Eur J Obstet Gynecol Reprod Biol. 2020 Mar; 246:194-196. . View in PubMed

Twin-Twin Transfusion Syndrome Complicated by Proximate Placental Cord Insertion Sites: Endoscopic Clip-Assisted Laser Occlusion Fetal Diagn Ther. 2020; 47(10):779-784. . View in PubMed

Nivolumab use for BRCA gene mutation carriers with recurrent epithelial ovarian cancer: A case series Gynecol Oncol Rep. 2018 Aug; 25:98-101. . View in PubMed

Single Marital Status and Infectious Mortality in Women With Cervical Cancer in the United States Int J Gynecol Cancer. 2017 10; 27(8):1737-1746. . View in PubMed

Extent of pelvic lymphadenectomy and use of adjuvant vaginal brachytherapy for early-stage endometrial cancer Gynecol Oncol. 2017 03; 144(3):515-523. . View in PubMed

Endoplasmic reticulum stress in complex atypical hyperplasia as a possible predictor of occult carcinoma and progestin response Gynecol Oncol. 2016 Dec; 143(3):650-654. . View in PubMed

Microfocus of Anaplastic Carcinoma Arising in Mural Nodule of Ovarian Mucinous Borderline Tumor With Very Rapid and Fatal Outcome Int J Gynecol Pathol. 2016 Jul; 35(4):348-51. . View in PubMed

Safety and feasibility of fasting in combination with platinum-based chemotherapy BMC Cancer. 2016 06 10; 16:360. . View in PubMed

Langerhans cells from women with cervical precancerous lesions become functionally responsive against human papillomavirus after activation with stabilized Poly-I:C Clin Immunol. 2015 Dec; 161(2):197-208. . View in PubMed

Immunohistochemical panel to differentiate endometrial stromal sarcoma, uterine leiomyosarcoma and leiomyoma: something old and something new J Clin Pathol. 2015 Sep; 68(9):710-7. . View in PubMed

Endometrioid adenocarcinoma associated with endometrial stromal sarcoma: A rare, often unrecognized collision tumor Gynecol Oncol Rep. 2015 Aug; 13:8-12. . View in PubMed

Phase I clinical trial of temsirolimus and vinorelbine in advanced solid tumors Cancer Chemother Pharmacol. 2014 Dec; 74(6):1227-34. . View in PubMed

Pemetrexed and cisplatin for the treatment of advanced, persistent, or recurrent carcinoma of the cervix: a limited access phase II trial of the gynecologic oncology group J Clin Oncol. 2014 Sep 01; 32(25):2744-9. . View in PubMed

Pharmacodynamic stimulation of thrombogenesis by angiotensin (1-7) in recurrent ovarian cancer patients receiving gemcitabine and platinum-based chemotherapy Cancer Chemother Pharmacol. 2013 Apr; 71(4):965-72. . View in PubMed

Predictive model of venous thromboembolism in endometrial cancer Gynecol Oncol. 2013 Mar; 128(3):544-51. . View in PubMed

Phase II study of gemcitabine and docetaxel in recurrent platinum resistant ovarian cancer Cancer Invest. 2012 May; 30(4):295-9. . View in PubMed

Margin distance and other clinico-pathologic prognostic factors in vulvar carcinoma: a multivariate analysis Gynecol Oncol. 2007 Mar; 104(3):636-41. . View in PubMed

Suppression of ovarian cancer cell tumorigenicity and evasion of Cisplatin resistance using a truncated epidermal growth factor receptor in a rat model Cancer Res. 2005 Apr 15; 65(8):3243-8. . View in PubMed

Conservative clitoral preservation surgery in the treatment of vulvar squamous cell carcinoma Gynecol Oncol. 2004 Oct; 95(1):152-6. . View in PubMed

After obtaining his medical degree from UC San Diego, Dr. Pham completed his internship and residency at Washington University Barnes-Jewish Hospital in St. Louis. After finishing his fellowship in gynecologic cancer at UC Irvine, Dr. Pham joined the Division of Gynecologic Oncology at USC. He is interested in the full range of female pelvic malignancy with special emphasis on clinical trials focused on chemotherapy for gynecology malignancies. At USC, Dr. Pham is the assistant director of clinical research in the Division of Gynecologic Oncology and is the principle investigator for the Group of Gynecologic Oncology trials at USC.
Powered by SC CTSI